Arctic Bioscience AS (OSL:ABS)
Norway · Delayed Price · Currency is NOK 2.410
0.00 (0.00%)
Oct 13, 2026, 3:47 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 64.96 million as of October 13, 2026. It is the 43,674th most valuable company in the world and the 266th biggest in Norway. Its market cap has decreased by 29.69% in one year.
Market Cap
64.96M
Enterprise Value
145.19M
Revenue
48.96M
Global Rank
Country Rank
#266 Norway
PE Ratio
n/a
ChartMarket Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 64.96M, a decrease of -90.28%. That is a compound annual growth rate of -33.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 64.96M | -26.52% |
| Dec 30, 2025 | 88.42M | 90.44% |
| Dec 30, 2024 | 46.43M | -82.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Circio Holding ASA | 2.99B |
| Thor Medical ASA | 1.85B |
| Nykode Therapeutics AS | 1.05B |
| ArcticZymes Technologies ASA | 980.57M |
| Lytix Biopharma ASA | 616.74M |
| Zelluna ASA | 561.38M |
| Oncoinvent ASA | 419.18M |
| SoftOx Solutions AS | 304.41M |